Kolexia
Jary Marine Oncologie médicale
Jary Marine
Oncologie médicale
Hôpital Estaing
Clermont-Ferrand, France
129 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Carcinomes Adénocarcinome Métastase tumorale Carcinome épidermoïde Récidive tumorale locale Tumeurs de l'estomac Tumeurs de l'anus Tumeurs du foie

Collaborateurs

Voir plus
Borg Christophe
Borg Christophe
Hôpital Nord Franche-Comté, Montbéliard, France
Nguyen-Tan-Hon Thierry
Nguyen-Tan-Hon Thierry
Le Mittan Annexe Du Hnfc, Montbéliard, France
Kim Chong Hun
Kim Chong Hun
Hôpital Saint-Jacques de Besançon, Besançon, France
Vienot Angelique
Vienot Angelique
Le Mittan Annexe Du Hnfc, Montbéliard, France

Industries

Voir plus
Servier
8 collaboration(s)
Dernière en 2022
Sanofi
5 collaboration(s)
Dernière en 2022
AstraZeneca
3 collaboration(s)
Dernière en 2023
Amgen
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
SCARCE: A Non-comparative Randomized 2:1 Phase II Study of Docetaxel, Cisplatin, and 5-fluorouracil in Combination or Not With Atezolizumab in Patients With Metastatic or Unresectable Locally Advanced Squamous Cell Anal Carcinoma
Essai Clinique (Roche)   08 mars 2024
Colibactin-producing enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence.
Gut microbes   19 février 2024
TASKIN: Multicentric Randomized Phase I/II Study to Evaluate Efficacy of Trifluridine/Tipiracil Plus XB2001 (Anti-IL-1α True Human Antibody) Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine
Essai Clinique (Centre Georges-François Leclerc)   12 février 2024
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   17 janvier 2024
GEMPAX: A Phase III Randomized Study Evaluating Gemcitabine and Paclitaxel Versus Gemcitabine Alone After FOLFIRINOX Failure or Intolerance in Metastatic Pancreatic Ductal Adenocarcinoma
Essai Clinique (Unicancer)   07 novembre 2023
COBRAF: A Study to Collect Patients, Medical, and Biological Data From Patients Being Treated for Metastatic Colorectal Cancer With a Specific Genetic Mutation: BRAFV600E
Essai Clinique (Pierre Fabre)   07 novembre 2023
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?
Cancer chemotherapy and pharmacology   07 novembre 2023
NEONIPIGA: Peri-operative Association of Immunotherapy (Pre-operative Association of Nivolumab and Ipilimumab, Post-operative Nivolumab Alone) in Localized Microsatellite Instability (MSI) and/or Deficient Mismatch Repair (dMMR) Oeso-gastric Adenocarcinoma: An Open-label GERCOR Phase II Study
Essai Clinique (BMS)   27 septembre 2023
Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study.
Cancers   15 juin 2023
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.
Cancers   06 avril 2023